20 year old female with chronic cough

Reading File
Finding Sources
Finding Sources
Searching PubMed

"chronic cough" young adults diagnosis management

Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Loading Image
Reading File
Finding Sources
Reading File
Reading File
Searching PubMed

"chronic cough" diagnosis guidelines

I now have comprehensive content. Let me compile the full clinical answer.

Chronic Cough in a 20-Year-Old Female

Chronic cough is defined as cough lasting >8 weeks. In a young woman with no smoking history and no ACE inhibitor use, the differential is distinct from older patients and deserves a systematic approach.

Management Algorithm

Chronic cough algorithm - Murray & Nadel's Textbook of Respiratory Medicine
Algorithm for chronic cough management in adults (Murray & Nadel's Textbook of Respiratory Medicine)

Differential Diagnosis

Most Common Causes (account for the vast majority of cases with a normal CXR)

CauseKey Features
Upper Airway Cough Syndrome (UACS) / Postnasal DripSensation of drip at back of throat, frequent throat clearing, cobblestoning of posterior pharynx, rhinosinusitis on CT
Asthma / Cough-Variant AsthmaEpisodic, worse with exercise, cold air, laughing; wheeze may be absent; reversible airflow obstruction on spirometry
Gastroesophageal Reflux Disease (GERD)Retrosternal burning, worse after meals or recumbency; cough may occur without typical heartburn symptoms
Non-Asthmatic Eosinophilic Bronchitis (NAEB)Dry cough, normal spirometry and methacholine challenge, >3% eosinophils on induced sputum; treated with inhaled corticosteroids
Postnasal drip, asthma, and GERD are classically described as the "big three," but clinical experience shows they do not account for all cases, and strict adherence to this triad can miss other causes. - Murray & Nadel's Textbook of Respiratory Medicine

Important Causes in Young Women Specifically

  • Sarcoidosis - can present in young adults with chronic dry cough and an abnormal chest radiograph (bilateral hilar lymphadenopathy). Sarcoidosis and Hodgkin's disease are specifically flagged by Harrison's as causes of chronic cough in young adults that may produce no other symptoms but show radiographic findings.
  • Pertussis (whooping cough) - consider in subacute-to-chronic cough; paroxysmal, may have posttussive vomiting or whooping quality; vaccine immunity wanes in adults.
  • Postinfectious cough - common after viral URI, typically self-limiting but can last weeks to months.
  • Cough Hypersensitivity Syndrome (CHS) - dry or minimally productive cough with a tickle/sensitivity in the throat; worsened by talking, laughing, exertion; more common in women than men; can persist for years; a neuropathic model (sensitized sensory nerve endings).
  • Psychogenic / Habit Cough - diagnosis of exclusion; consider if cough is absent during sleep and has a honking, barking quality.
  • Vocal cord dysfunction / Inducible laryngeal obstruction - episodic inspiratory stridor/cough, often misdiagnosed as asthma.
  • Bronchiectasis - productive cough, recurrent infections; consider if there is a history of childhood infections, immunodeficiency, or cystic fibrosis (in a 20-year-old, CF should be on the radar).
  • Cystic fibrosis - in a young woman with chronic productive cough, CF must be considered even if mild/atypical phenotype.
  • Pulmonary tuberculosis - worldwide a leading cause of chronic cough; consider with relevant exposure history, weight loss, or night sweats.

Workup

Step 1 - History

  • Duration, character (dry vs. productive, sputum color/amount)
  • Timing (nocturnal, postprandial, seasonal, exercise-related)
  • Associated: wheeze, dyspnea, heartburn, postnasal drip, throat clearing, rhinorrhea
  • Triggers: cold air, laughing, perfumes, smoke
  • Medications: ACE inhibitors (unlikely in a 20-year-old, but check)
  • Smoking history, occupational/environmental exposures
  • Family history (CF, asthma, atopy)
  • Recent respiratory infections
  • Features of cough hypersensitivity: tickling sensation, cough with talking, paroxysms

Step 2 - Physical Examination

  • Nasal exam: mucosa edema, polyps, secretions
  • Pharynx: cobblestoning (postnasal drip)
  • Chest: wheeze, crackles
  • Ear canals: Arnold's nerve irritation can trigger cough
  • Nails: clubbing
  • General: lymphadenopathy, skin changes (sarcoidosis)

Step 3 - Initial Investigations

InvestigationRationale
Chest X-rayMandatory first step; may reveal hilar lymphadenopathy (sarcoid/lymphoma), infiltrates (TB, pneumonia), bronchiectasis
Spirometry with bronchodilator reversibilityDiagnose asthma/COPD
Methacholine challenge testIf spirometry normal but asthma suspected; high sensitivity for asthma
Skin prick testing / specific IgEAllergic rhinitis assessment
Sinus CTIf rhinosinusitis suspected and not responding to empiric treatment
Induced sputum for eosinophilsDiagnose eosinophilic bronchitis (>3% eosinophils, normal methacholine)
24-hr esophageal pH monitoringGold standard for GERD; indicated if symptoms suggest reflux or empiric PPI trial fails

Step 4 - Further Investigations (if initial workup unrevealing)

  • HRCT chest - bronchiectasis, interstitial disease, sarcoidosis
  • Fiberoptic bronchoscopy - small central tumors, mucosal biopsy (sarcoid, eosinophilic infiltration), culture
  • Sweat chloride / CFTR genotyping - if CF suspected
  • Laryngoscopy - vocal cord dysfunction, laryngopharyngeal reflux
  • Pertussis serology (IgA/IgG) - if subacute/chronic and no other explanation

Empiric Treatment Approach

Treat the most likely diagnosis based on history and examination while investigations are pending:
Suspected CauseFirst-Line Treatment
UACS / Allergic rhinitisIntranasal corticosteroid + antihistamine; add ipratropium for excessive secretions
Asthma / Cough-variant asthmaInhaled corticosteroid (ICS) + short-acting bronchodilator as needed
GERDPPI once daily for 8 weeks; lifestyle measures (elevate head of bed, weight loss if applicable); note: empiric PPI has low specificity
Eosinophilic bronchitisInhaled corticosteroids
PostinfectiousReassurance; consider short course of intranasal steroids if nasal symptoms present

Refractory / Unexplained Cough

If cough persists despite treating identified causes:
  1. Reassess compliance with therapy
  2. Consider cough hypersensitivity syndrome as the primary or contributing mechanism
  3. Pharmacologic neuromodulation: low-dose gabapentin (300-1800 mg/day) or pregabalin have evidence for refractory chronic cough; amitriptyline (low dose) is also used
  4. Speech pathology / cough suppression therapy: breathing exercises, cough suppression techniques, laryngeal hygiene - particularly effective in women with concurrent vocal cord dysfunction or muscle tension dysphonia
  5. Refer to specialist cough clinic
Cough hypersensitivity syndrome is more common in women and presents as a dry cough with a tickle or sensitivity in the throat, worsened by talking, laughing, or exertion. It can last for years and is a diagnosis of exclusion. - Harrison's Principles of Internal Medicine 22E

Red Flags Requiring Urgent Workup

  • Hemoptysis
  • Weight loss, night sweats
  • Clubbing
  • Abnormal chest X-ray
  • Stridor or signs of airway obstruction
  • Immunosuppression or TB exposure

Summary Approach for This Patient

A 20-year-old female with chronic cough and no obvious red flags should have:
  1. Thorough history and physical examination
  2. Chest X-ray (exclude sarcoidosis, TB, lymphoma in this age group)
  3. Spirometry with reversibility testing
  4. Empiric treatment targeting the most likely cause identified clinically (usually UACS, asthma, or GERD)
  5. Stepwise investigation if initial workup and treatment are unrevealing
  6. Keep CF in mind if productive cough and recurrent infections
Sources: Harrison's Principles of Internal Medicine 22E (2025), Murray & Nadel's Textbook of Respiratory Medicine, Goldman-Cecil Medicine
A 2025 practice guideline (PMID: 41385480) reaffirms this stepwise algorithm for adult cough diagnosis and treatment.

20 year old female with chronic cough since 21 days and had a history of smoking

Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Searching PubMed

"pertussis" adults cough diagnosis

I now have comprehensive material. Let me compose the full clinical answer.

Subacute Cough in a 20-Year-Old Female Smoker

Critical Clarification: This is Subacute Cough, Not Chronic

DurationClassification
< 3 weeksAcute
3 - 8 weeksSubacute
> 8 weeksChronic
At 21 days, this patient is at the boundary of acute and subacute cough. The diagnostic approach differs meaningfully from chronic cough. However, given her smoking history, certain chronic causes must still be considered even at this early stage.

Differential Diagnosis

Most Likely Causes

1. Postinfectious Cough (Most Common Cause of Subacute Cough) The #1 cause of subacute cough overall. Mechanisms include:
  • Postviral airway inflammation with bronchial hyperresponsiveness
  • Mucus hypersecretion
  • Upper airway cough syndrome (postnasal discharge)
  • Unmasking of underlying asthma
Look for a history of preceding URI (runny nose, sore throat, fever) 1-3 weeks prior. Chest X-ray is typically normal.
"Postinfectious cough is the most likely cause of subacute cough. The mechanisms include postviral airway inflammation with bronchial hyperresponsiveness, mucus hypersecretion, upper airway cough syndrome (postnasal discharge), or asthma." - Tintinalli's Emergency Medicine

2. Pertussis (Bordetella pertussis) - Must Not Miss Particularly important in a 20-year-old as vaccine immunity wanes by early adulthood.
Classic features:
  • Paroxysmal coughing fits followed by an inspiratory whoop (may be absent in adults)
  • Posttussive vomiting
  • Cough worsens over the first 1-2 weeks (catarrhal → paroxysmal phase)
  • Absence of fever between episodes
  • Can last 6-10 weeks ("100-day cough")
Diagnosis: PCR nasopharyngeal swab (best sensitivity in first 3 weeks - this patient is still in window). Serology (IgA/IgG) if >3 weeks.
"The observed increased incidence of pertussis in adolescents and young adults is likely due to waning vaccine immunity with increasing age." - Tintinalli's Emergency Medicine
Note: A 2025 clinical review (PMID: 40387798) reaffirms that pertussis is underdiagnosed in adults and should be considered in any subacute cough.

3. Smoking-Related Airway Irritation / Acute Bronchitis Cigarette smoking directly irritates airways and impairs mucociliary clearance, making smokers prone to:
  • Prolonged cough after any respiratory infection
  • Acute bronchitis with productive cough
  • Early features of chronic bronchitis if smoking is ongoing
Smoking-induced coughing is usually worse in the morning and, with chronic bronchitis, usually productive. - Tintinalli's Emergency Medicine
Cessation of cigarette smoking is usually accompanied by a reduction in cough, most often within 4 to 5 weeks. - Murray & Nadel's Textbook of Respiratory Medicine

4. Asthma / Cough-Variant Asthma Smoking is a known asthma trigger. Subacute cough following a URI can unmask previously undiagnosed asthma or represent a flare of known asthma.
  • Cough worse at night, with exercise, cold air, laughing
  • Episodic wheeze or dyspnea
  • Spirometry may show reversible airflow obstruction; methacholine challenge if spirometry normal

5. Upper Airway Cough Syndrome (UACS) / Postnasal Drip
  • Sensation of secretions dripping down the back of the throat
  • Frequent throat clearing
  • Can be allergic or non-allergic rhinitis/sinusitis
  • Smoking worsens nasal mucosal inflammation

6. Atypical Pneumonia (Mycoplasma, Chlamydophila) In a young adult with cough of 3 weeks, atypical organisms must be considered:
  • Mycoplasma pneumoniae: dry/hacking cough, low-grade fever, "walking pneumonia"
  • Chlamydophila pneumoniae: similar presentation
  • Chest X-ray may show patchy infiltrates disproportionate to clinical severity
"Subacute cough caused by Bordetella pertussis, Mycoplasma pneumoniae, and Chlamydophila pneumoniae should prompt a chest radiograph, molecular testing, and appropriate antibiotic treatment." - Goldman-Cecil Medicine

7. Acute Exacerbation of Underlying Airway Disease In a smoker, even at 20 years old, consider that she may have undiagnosed early airway disease (chronic bronchitis, mild COPD phenotype) that is now manifesting.

Less Likely But Important to Consider

DiagnosisWhy Consider
PneumoniaSmokers have impaired airway defenses; fever, productive cough, CXR changes
Pulmonary tuberculosisIf relevant exposure, weight loss, night sweats
GERDCan trigger or worsen cough
Foreign body aspirationSudden onset cough without preceding illness
Smoking cessation (if recently quit)Paradoxical increase in cough for 1-4 weeks as mucociliary function recovers

Workup

Step 1 - Focused History

QuestionSignificance
Preceding URI/fever?Postinfectious cough
Paroxysmal fits + posttussive vomiting?Pertussis
Wheeze, nocturnal cough, atopy?Asthma
Heartburn, worse lying down?GERD
Postnasal drip, throat clearing, rhinorrhea?UACS
Productive sputum - color?Bacterial infection, bronchitis
Current smoker or recently quit?Quantity (pack-years), quitting status
Vaccinations: Tdap booster?Pertussis vaccination status
Weight loss, night sweats, contacts?TB

Step 2 - Physical Examination

  • Temperature, SpO₂, RR - rule out acute illness
  • Nasal exam: polyps, secretions, mucosal edema
  • Pharynx: cobblestoning, postnasal secretions
  • Chest auscultation: wheeze, crackles, reduced breath sounds
  • Lymphadenopathy

Step 3 - Investigations

TestIndication
Chest X-rayMandatory - pneumonia, TB, atypical features
Nasopharyngeal PCR for B. pertussisStill in window at 21 days - order now or you'll miss it
SpirometryIf asthma or airflow obstruction suspected
Sputum culture (if productive)Bacterial pathogens, AFB if TB considered
Mycoplasma/Chlamydophila serology or PCRIf walking pneumonia presentation
Peak flow variabilityIf cough-variant asthma suspected
Note: "PCR and culture have decreasing sensitivity after the third week of coughing" for pertussis - this patient is at exactly that threshold. Act quickly. - Tintinalli's Emergency Medicine

Management

If Postinfectious (No Specific Pathogen Identified)

  • Reassurance: most resolve within 3-8 weeks
  • Treat any identified component (postnasal drip → intranasal steroid; bronchospasm → short-acting bronchodilator)
  • Smoking cessation - single most important intervention; reduces cough within 4-5 weeks
  • Honey + warm fluids for symptomatic relief
  • Short course of inhaled bronchodilator if bronchial hyperresponsiveness suspected

If Pertussis Confirmed / Strongly Suspected

  • Azithromycin 500 mg day 1, then 250 mg days 2-5 (macrolide of choice)
  • Alternatively: clarithromycin or TMP-SMX
  • Reduces transmission even if started late; may shorten illness if started in first 3 weeks
  • Contact tracing and post-exposure prophylaxis for close contacts
  • Advise Tdap booster for patient and household contacts

If Cough-Variant Asthma

  • Inhaled corticosteroid (ICS) + short-acting bronchodilator
  • Smoking cessation is mandatory

If Atypical Pneumonia

  • Azithromycin or doxycycline for Mycoplasma or Chlamydophila

Smoking Cessation - Priority Regardless of Cause

Smoking is a direct cause and amplifier of cough at any age. At 20 years old, cessation now prevents progression to chronic bronchitis, COPD, and lung cancer. Offer:
  • Brief counseling ("5 A's")
  • Nicotine replacement therapy (NRT) - patch, gum, or lozenge
  • Varenicline (most effective pharmacotherapy) or bupropion

Summary for This Patient

PriorityAction
1Chest X-ray
2Nasopharyngeal PCR for pertussis (time-sensitive - within window)
3Assess for and address smoking cessation
4Empiric treatment targeting most likely cause (postinfectious/bronchospasm)
5Spirometry if wheeze or airflow obstruction suspected
6Return if not improving by 8 weeks → full chronic cough workup
"If postinfectious, then assess for transient bronchial hyperresponsiveness, asthma, pertussis, upper airway cough syndrome, pneumonia, or an acute exacerbation of chronic bronchitis. Treatment is then directed at the presumed cause. If subacute cough is not postinfectious, it is evaluated and treated in the same manner as a chronic cough." - Tintinalli's Emergency Medicine

Sources: Tintinalli's Emergency Medicine, Murray & Nadel's Textbook of Respiratory Medicine, Goldman-Cecil Medicine, Harrison's Principles of Internal Medicine 22E

Trarment of chronic cough

Finding Sources
Finding Sources
Searching PubMed

"chronic cough" treatment guidelines

Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
I now have comprehensive, authoritative content to compile the full treatment guide. Let me write it up.

Treatment of Chronic Cough

The fundamental principle is: identify and treat the cause first. Symptom-directed suppression is only used when cause-specific treatment fails or no cause is found.

Step 1 - Remove Precipitating Agents First

Before any other therapy:
AgentAction
ACE inhibitorStop immediately; switch to ARB (does not cause cough). Reassess at 1 month.
SmokingCessation reduces cough within 4-5 weeks; mandatory in smokers
Environmental/occupational irritantsIdentify and eliminate
"Patients with chronic cough while on ACE inhibitor therapy should discontinue such therapy, with replacement by other appropriate treatments." - Murray & Nadel's Textbook of Respiratory Medicine

Step 2 - Cause-Directed Treatment

A. Upper Airway Cough Syndrome (UACS) / Postnasal Drip

DrugDetails
Intranasal corticosteroid (1st line)e.g., fluticasone, mometasone - local effect, minimal systemic side effects; head-down position for drops
Oral/intranasal antihistamineCombined with nasal steroid; adds benefit
Intranasal ipratropium bromideDries excessive nasal secretions; useful add-on
Short course oral corticosteroidFor severe symptoms initially, then taper to topical
AntibioticsOnly if bacterial sinusitis confirmed

B. Asthma / Cough-Variant Asthma

DrugDetails
Inhaled corticosteroid (ICS)First-line; reduces airway eosinophilic inflammation
Short-acting β₂ agonist (SABA)e.g., salbutamol - as needed for symptoms
Long-acting β₂ agonist (LABA)Added to ICS if inadequate control
Leukotriene receptor antagoniste.g., montelukast - useful adjunct, especially in allergic component
Smoking cessationSmoking is a direct asthma trigger

C. Gastroesophageal Reflux Disease (GERD)

TreatmentDetails
Lifestyle measuresElevate head of bed, weight loss, avoid coffee/fatty foods/late meals, avoid smoking
Proton pump inhibitor (PPI)e.g., omeprazole 20-40 mg daily; give for minimum 8 weeks
H₂ antagoniste.g., ranitidine - less effective than PPI but an option
ProkineticsDomperidone, metoclopramide - limited evidence, potential side effects
Antireflux surgeryLaparoscopic fundoplication for refractory GERD-related cough; evidence unclear
Note: Evidence does not support empiric PPI for cough without reflux symptoms. PPI is most effective when abnormal esophageal acid exposure is confirmed on pH monitoring. - Murray & Nadel's Textbook of Respiratory Medicine

D. Non-Asthmatic Eosinophilic Bronchitis (NAEB)

DrugDetails
Inhaled corticosteroidFirst-line; highly effective
Leukotriene inhibitorAdjunct

E. Chronic Bronchitis / COPD

TreatmentDetails
Smoking cessationSingle most important intervention
Short-acting bronchodilator (SABA/SAMA)Salbutamol or ipratropium
Long-acting bronchodilator (LABA/LAMA)For persistent symptoms
ICS + LABA combinationFor airway inflammation
MucolyticsAcetylcysteine, carbocysteine - reduce exacerbation frequency, ease expectoration

F. Bronchiectasis

TreatmentDetails
Chest physiotherapy / postural drainageCornerstone - improves airway clearance
Inhaled β₂ agonistsImprove mucociliary clearance, reverse bronchoconstriction
AntibioticsTargeted to cultured pathogens during infective exacerbations
Long-term macrolidee.g., azithromycin 3x/week - reduces exacerbations and improves lung function

G. Infective Tracheobronchitis / Postinfectious

TreatmentDetails
Appropriate antibioticsMacrolide for pertussis/Mycoplasma; doxycycline for Chlamydophila
Treat postnasal drip componentIntranasal steroid if present
Short-acting bronchodilatorIf bronchial hyperresponsiveness present

Step 3 - Symptomatic / Cough Suppression Therapy

Used when cause-directed treatment fails, is unavailable, or cough hypersensitivity syndrome is the primary mechanism.

A. Non-Pharmacologic: Speech Pathology (First-Line for Refractory)

A structured program delivered by a speech therapist or respiratory physiotherapist:
  • Breathing retraining exercises
  • Cough suppression techniques (urge-to-cough control)
  • Vocal and laryngeal hygiene training
  • Psychoeducational counseling
Proven to improve cough symptom scores, cough counts, breathing, voice, and upper airway symptoms. Particularly effective in patients with concurrent muscle tension dysphonia or vocal cord dysfunction.
"Speech pathology management... has been shown to be effective in improving cough symptom scores and cough counts." - Murray & Nadel's Textbook of Respiratory Medicine

B. Pharmacologic Antitussives

1. Narcotic Antitussives (Most Potent)

DrugDetails
CodeineStandard centrally acting antitussive; mixed efficacy; risk of dependence, constipation, sedation
Slow-release morphineFor severe chronic refractory cough; reserved for cases significantly affecting quality of life or palliative use
HydrocodoneUsed in some guidelines for refractory cough
"Most potent are narcotic cough suppressants, such as codeine, hydrocodone, or morphine, which are thought to act in the 'cough center' in the brainstem. The tendency to cause drowsiness and constipation and their potential for addictive dependence limit their appeal for long-term use." - Harrison's Principles of Internal Medicine 22E

2. Non-Narcotic Antitussives

DrugMechanismNotes
DextromethorphanCentral; different site from opioidsOTC; as effective as codeine for acute/chronic cough; fewer side effects; avoid with MAOIs (serotonin syndrome risk)
BenzonatateInhibits sensory nerve activity in cough reflex pathwayGenerally free of side effects; variable/unpredictable efficacy
LevodropropizinePeripheral inhibition of sensory cough receptorsFavorable benefit/risk vs dextromethorphan
Inhaled lidocaineBlocks voltage-gated Na⁺ channelsTransient suppression; risk of aspiration due to oropharyngeal anesthesia

3. Neuromodulators (For Cough Hypersensitivity Syndrome / Refractory Cough)

These target the sensitized sensory neural pathways underlying chronic refractory cough - treating it as a neuropathic condition.
DrugEvidenceDose (typical)
GabapentinRCT: reduced cough frequency, improved Leicester Cough QoL scores300-1800 mg/day in divided doses; titrate up
PregabalinRCT: combined with speech therapy reduced cough severity and frequency vs speech therapy alone75-300 mg/day
AmitriptylineProspective RCT: superior to codeine/guaifenesin for postinfectious cough10-25 mg at night (low dose)
"In a randomized controlled double-blind trial in patients with refractory cough, gabapentin was effective in reducing cough frequency and visual analogue scores while improving Leicester Cough quality-of-life scores." - Murray & Nadel's Textbook of Respiratory Medicine
Both gabapentin and amitriptyline likely act via central antinociceptive mechanisms, modulating presynaptic NMDA receptors and reducing postsynaptic excitability.

4. Expectorants and Mucolytics

DrugUse
Acetylcysteine / CarbocysteineReduce sputum viscosity in chronic bronchitis; small reduction in exacerbations
Bromhexine / AmbroxolMucolytic; facilitates expectoration
Menthol / EucalyptusAromatic; decongestant in nose; menthol inhibits capsaicin-induced cough via TRPM8 receptor
Honey + warm liquidsSafe, mild symptomatic benefit; supported for acute cough; useful adjunct
DemulcentsProtective layer on mucosal surface; component of most proprietary cough preparations

Step 4 - Emerging / Novel Therapies

Drug/ClassTargetStatus
GefapixantP2X2/3 ATP receptor antagonistPhase III trials - 75% reduction in cough frequency in phase II; main side effect: dysgeusia (taste disturbance)
Selective P2X3 antagonistsMore specific than gefapixantEarly development; may reduce taste side effects
NaV1.7 blockersVoltage-gated Na⁺ channel subunitPreclinical
NK-1 receptor antagonistsNeurokinin-1 in central cough pathwaysEarly phase II trials; improvement in cough frequency
TRPV1/TRPA1 antagonistsTRP channels on vagal afferentsClinical trials failed for chronic cough
Alpha-7 nicotinic agonistsCentral cough inhibitionIn development
"The most promising target currently is the ATP P2X2/3 receptor. A P2X2/3 antagonist, gefapixant, has shown efficacy in suppressing chronic cough in phase II clinical trials with a reduction in cough frequency of 75%." - Murray & Nadel's Textbook of Respiratory Medicine

Summary Treatment Table

(From Murray & Nadel's Textbook of Respiratory Medicine)
CauseTreatment
Asthma / cough-variant asthmaBronchodilators + ICS
Eosinophilic bronchitisICS; leukotriene inhibitors
Allergic rhinitis / postnasal dripTopical nasal steroids + antihistamines + ipratropium
GERDLifestyle changes + H₂ antagonist or PPI
ACE inhibitorDiscontinue → switch to ARB
Chronic bronchitis / COPDSmoking cessation + COPD therapy
BronchiectasisPostural drainage + antibiotics + airflow therapy
Infective tracheobronchitisAntibiotics + treat postnasal drip
Chronic cough (all)Speech and language therapy
Refractory cough affecting QoLAmitriptyline or gabapentin
Severe chronic refractory coughSlow-release morphine

When to Refer

  • No response after treating identified cause(s)
  • Diagnosis uncertain
  • Consider: specialist cough clinic, pulmonologist, gastroenterologist (pH monitoring), ENT (laryngoscopy), speech pathologist

Sources: Murray & Nadel's Textbook of Respiratory Medicine, Harrison's Principles of Internal Medicine 22E (2025), Tintinalli's Emergency Medicine, Goldman-Cecil Medicine
A 2025 German Respiratory Society practice guideline (PMID: 41385480) supports this stepwise, cause-directed approach with neuromodulators reserved for refractory cases.
This is a shared conversation. Sign in to Orris to start your own chat.